Home / Resources and Insights / Webinar: Challenges and Opportunities in Peptide Drug Conjug...
Webinar: Challenges and Opportunities in Peptide Drug Conjugates (PDCs)
Less than 1 min read time
PDCs have gained extensive attention as they are being proven successful in treating cancers recently with their superior target-specific delivery.
PDCs combine peptides and linker-toxins, their development and manufacturing require comprehensive synthetic chemistry, process development, analytical method development, and manufacturing capabilities for both highly potent small molecules and peptides, which often bring technical challenges, especially during scale-up.
Here we discuss how we overcome challenges and demonstrate opportunities through case studies.
Gated content
Please complete the form below to access this content.
Related Reading
Accelerating Novel Peptides into Clinical Trials with Integrated Partnership
Do you have peptide drug candidates in development?
Overcoming Key Challenges in PROTAC Drug Development
Pharmaceutical development of PROTAC (Proteolysis Targeting Chimeras) molecules presents significant challenges due to their complex molecular structures, leading to low...
